ZA916313B - New use of a monoclonal antibody - Google Patents

New use of a monoclonal antibody

Info

Publication number
ZA916313B
ZA916313B ZA916313A ZA916313A ZA916313B ZA 916313 B ZA916313 B ZA 916313B ZA 916313 A ZA916313 A ZA 916313A ZA 916313 A ZA916313 A ZA 916313A ZA 916313 B ZA916313 B ZA 916313B
Authority
ZA
South Africa
Prior art keywords
monoclonal antibody
new use
specificity
fragments
variants
Prior art date
Application number
ZA916313A
Other languages
English (en)
Inventor
Hans Loibner
Loibner Hans
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA916313B publication Critical patent/ZA916313B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
ZA916313A 1990-08-11 1991-08-09 New use of a monoclonal antibody ZA916313B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen

Publications (1)

Publication Number Publication Date
ZA916313B true ZA916313B (en) 1993-04-28

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916313A ZA916313B (en) 1990-08-11 1991-08-09 New use of a monoclonal antibody

Country Status (13)

Country Link
EP (1) EP0547079B1 (xx)
JP (1) JPH06500771A (xx)
KR (1) KR930701193A (xx)
AT (1) ATE136469T1 (xx)
AU (1) AU657489B2 (xx)
CA (1) CA2088370C (xx)
DE (2) DE4025499A1 (xx)
HU (1) HUT64238A (xx)
IE (1) IE912823A1 (xx)
PT (1) PT98622A (xx)
TW (1) TW223019B (xx)
WO (1) WO1992003165A1 (xx)
ZA (1) ZA916313B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2145004T3 (es) * 1991-08-21 2000-07-01 Novartis Ag Derivados de anticuerpos.
CZ286547B6 (cs) * 1992-05-22 2000-05-17 Novartis Ag Monoklonální protilátky a jejich použití
AU5503899A (en) * 1998-06-29 2000-01-17 Wolfgang Bergter Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
KR930701193A (ko) 1993-06-11
AU657489B2 (en) 1995-03-16
AU8393291A (en) 1992-03-17
WO1992003165A1 (en) 1992-03-05
IE912823A1 (en) 1992-02-12
DE69118702D1 (de) 1996-05-15
PT98622A (pt) 1992-06-30
TW223019B (xx) 1994-05-01
HU9300349D0 (en) 1993-05-28
ATE136469T1 (de) 1996-04-15
CA2088370A1 (en) 1992-02-12
HUT64238A (en) 1993-12-28
EP0547079A1 (en) 1993-06-23
DE4025499A1 (de) 1992-02-13
DE69118702T2 (de) 1996-09-05
EP0547079B1 (en) 1996-04-10
JPH06500771A (ja) 1994-01-27
CA2088370C (en) 2003-03-25

Similar Documents

Publication Publication Date Title
IL103981A (en) CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
ATE93258T1 (de) Coextrusionsfaehige klebstoffe und damit hergestellte gegenstaende.
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
AU616156B2 (en) Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
DE68919172D1 (de) MOSFET und dessen Herstellungsverfahren.
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
EP0245993A3 (en) Monoclonal antibodies against c5a and des-arg74-c5a, their production and use
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
AU2784792A (en) Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
IT1264965B1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ZA916313B (en) New use of a monoclonal antibody
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
EP0456727A4 (en) Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
NO903801D0 (no) Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
IT8723085A0 (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse.
DE69101652D1 (de) Behandlungsofen.
AU657504B2 (en) Antibody against human plasmin-alpha2-plasmin inhibitor complex, hybridoma and immunoassay
NO893818L (no) Produksjon og anvendelse av hybride, monoklonale antistoffer.
FI961339A (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
DK8089D0 (da) Monoclonale antistoffer, deres fremstilling og anvendelse.
DE69009106D1 (de) Weiche Tasche und Expander.